Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
16 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/16/2963836/0/en/Neurogastrx-Announces-Positive-Proof-of-Concept-Data-for-Investigational-Drug-NG101-in-Reducing-Nausea-and-Vomiting-Associated-with-the-Administration-of-GLP-1-Agonist-Medication.html
05 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/daewoong-pharmaceutical-regaining-rights-to-fexuprazan-in-the-united-states-and-canada-upon-termination-of-license-agreement-with-neurogastrx-301841938.html
27 Aug 2021
// Kyle LaHucik FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/neurogastrx-served-platter-60m-for-phase-2-3-gi-drugs-adds-cmo-cfo-and-cbo
26 Aug 2021
// Jason Mast ENDPTS
https://endpts.com/after-pandemic-delay-and-a-south-korean-deal-boston-area-biotech-raises-series-b-with-sights-on-ipo/
ABOUT THIS PAGE